ghk-cu peptide dosage research Guide: Typical Protocols, Injection & Topical ghk-cu peptide subcutaneous dosing protocol

Consult your licensed prescriber to determine appropriate use

The Hostynek and Maibach group at UCSF measured exactly this in 2011: human skin permeation of GHK-Cu as a function of skin layer, with the result that the peptide accumulates in the upper stratum corneum but does not pass through to viable epidermis or dermis in any meaningful quantity 4

the Caprylocaproyl polyoxylglyceride is used in amounts from 0.5 - 25 %, preferably from 5 - 25 % and most preferably from 10 - 20 % of the composition

Take 600 mg twice daily

Independent clinical literature notes that BPC-157 injection dosing varies by indication and provider protocol